Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2003-05-28 (22 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VALENCIENNES (59300), Nord
SELARL PHARMACIE DE ROMAINVILLE : revenue, balance sheet and financial ratios
SELARL PHARMACIE DE ROMAINVILLE is a French company
founded 22 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VALENCIENNES (59300),
this company of category PME
shows in 2024 a revenue of 3.1 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DE ROMAINVILLE (SIREN 448731430)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
3 122 857 €
2 858 451 €
2 839 960 €
2 715 922 €
2 604 618 €
2 615 684 €
2 449 245 €
2 342 571 €
2 293 017 €
Net income
92 887 €
47 496 €
62 581 €
141 523 €
78 746 €
107 783 €
119 873 €
118 587 €
73 479 €
101 906 €
EBITDA
N/C
87 961 €
100 777 €
216 530 €
132 920 €
175 461 €
191 124 €
190 515 €
112 503 €
163 218 €
Net margin
N/C
1.5%
2.2%
5.0%
2.9%
4.1%
4.6%
4.8%
3.1%
4.4%
Revenue and income statement
In 2025, SELARL PHARMACIE DE ROMAINVILLE generates positive net income of 93 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 102 k€ -> 93 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
92 887 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 43%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 56%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
43.102%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
56.398%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DE ROMAINVILLE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
41.24
209.316
165.222
127.391
105.211
89.227
69.827
60.265
54.002
43.102
Financial autonomy
59.868
27.609
32.111
37.243
41.159
43.816
48.194
50.788
52.34
56.398
Repayment capacity
4.1
14.289
8.214
7.127
7.183
8.511
4.442
7.966
8.298
None
Cash flow / Revenue
5.063%
3.615%
5.558%
5.433%
4.903%
3.558%
5.72%
2.763%
2.217%
None%
Sector positioning
Debt ratio
43.12025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Good
In 2025, the debt ratio of SELARL PHARMACIE DE ROMAI... (43.10) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
56.4%2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Good
In 2025, the financial autonomy of SELARL PHARMACIE DE ROMAI... (56.4%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
8.3 years2024
2023
2024
Q1: 0.52 years
Med: 3.18 years
Q3: 7.6 years
Average
In 2024, the repayment capacity of SELARL PHARMACIE DE ROMAI... (8.30) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 153.70. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
153.697
Liquidity indicators evolution SELARL PHARMACIE DE ROMAINVILLE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
148.679
163.742
152.837
160.389
165.592
138.532
131.244
133.646
130.488
153.697
Interest coverage
3.149
5.253
6.708
6.102
6.04
7.161
3.893
7.274
8.79
None
Sector positioning
Liquidity ratio
153.72025
2023
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Average+11 pts over 3 years
In 2025, the liquidity ratio of SELARL PHARMACIE DE ROMAI... (153.70) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
8.79x2024
2023
2024
Q1: 0.0x
Med: 2.34x
Q3: 7.73x
Excellent
In 2024, the interest coverage of SELARL PHARMACIE DE ROMAI... (8.8x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE DE ROMAINVILLE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
243 152 €
280 148 €
266 870 €
332 506 €
299 245 €
229 577 €
222 142 €
297 393 €
321 373 €
0 €
Inventory turnover (days)
41
42
41
42
46
35
35
38
37
0
Customer payment term (days)
6
5
5
9
6
6
4
3
5
0
Supplier payment term (days)
42
47
44
43
41
43
45
45
44
0
Positioning of SELARL PHARMACIE DE ROMAINVILLE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SELARL PHARMACIE DE ROMAINVILLE is estimated at
1 475 521 €
(range 1 001 295€ - 2 315 295€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1001k€1475k€2315k€
1 475 521 €Range: 1 001 295€ - 2 315 295€
NAF 5 année 2025
Valuation method used
Net Income Multiple
92 887 €
×
15.9x
=1 475 521 €
Range: 1 001 296€ - 2 315 296€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DE ROMAINVILLE with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DE ROMAINVILLE
What is the revenue of SELARL PHARMACIE DE ROMAINVILLE ?
The revenue of SELARL PHARMACIE DE ROMAINVILLE in 2024 is 3.1 M€.
Is SELARL PHARMACIE DE ROMAINVILLE profitable?
Yes, SELARL PHARMACIE DE ROMAINVILLE generated a net profit of 93 k€ in 2025.
Where is the headquarters of SELARL PHARMACIE DE ROMAINVILLE ?
The headquarters of SELARL PHARMACIE DE ROMAINVILLE is located in VALENCIENNES (59300), in the department Nord.
Where to find the tax return of SELARL PHARMACIE DE ROMAINVILLE ?
The tax return of SELARL PHARMACIE DE ROMAINVILLE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DE ROMAINVILLE operate?
SELARL PHARMACIE DE ROMAINVILLE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart